Introduction
============

Diabetes mellitus is one of the largest global health emergencies of the 21^st^ century[@R1]. Worldwide, the frequency of diabetes among 20--79 years aged adults was 6.4% (285 million individuals) in 2010 and it is estimated to be 7.7% (439 million individuals) in 2030. In the United States, 9.3% of the population (29.1 million individuals) had diabetes in 2014 and it is projected to increase by 54% between 2015 and 2030. Also, in Turkey the prevalence of diabetes is 13.7% and a significant proportion of our community is candidate for diabetes due to obesity and prediabetes[@R2],[@R3]. Individuals with diabetes bear a higher risk for life-threatening medical problems compared to individuals without diabetes. Continuous higher glycaemia may cause serious disorders affecting heart, blood vessels, eye, kidney and nerves. Moreover, individuals with diabetes are at increased risk for infection development. Complications of diabetes can be avoided with controlled glycaemia, blood pressure and cholesterol as close to normal as possible[@R4],[@R5]. In order to keep the complications under control and the quality of life satisfactory, patients with diabetes should be provided continuous medical and nursing care, and training on self-management. The main goal of treatment of diabetes is achieving a proper glycemic control, thereby minimizing the incidence of complications[@R5]--[@R7].

In maintaining a proper metabolic control, insulin therapy has a key role not only for patients with type 1 diabetes, but also for patients with type 2 diabetes[@R7]. Ready insulin pen is preferred by physicians and patients because of its easiness to use and safeness in dosage regulation[@R8],[@R9]. However, deficient injection techniques, such as repetitive use of insulin pen needle and not rotating the injection site, may hamper a successive glycemic control and requires attention[@R10],[@R11]. Literature review on patients with diabetes show that there are common errors on insulin pen use such as, preferring the same anatomical site for injection, not implementing the pinch up method correctly, using the pen needle multiple times, not performing rotations, etc.[@R12],[@R13] If attention is not devoted, patients may experience complications such as hypoglycemia, bleeding, ecchymosis and lipodystrophy on the injection site. Therefore, patients should be equipped with knowledge and skills to avoid these complications and benefit from the treatment[@R13]--[@R16].

There are descriptive studies which assess the attitudes of patients on insulin pen use by enquiries[@R16]--[@R19] but the studies that use observation of insulin injection as a tool of assessment in patients who self-administer insulin pen are limited[@R19],[@R20]. There are no studies assessing the proper injection of insulin with insulin pen, and the effectiveness of patient education by simulation. Given the fact that nearly 25% of medical expenses in Turkey arise from diabetes and diabetes related illnesses[@R5], control of diabetes bears a significant importance. Despite the decisive role of proper injection technique in achieving the optimal effect of insulin injection, it is rarely an attention payed and neglected step[@R14],[@R21]. Incorrect injection technique is one of the barriers to intended glycemic control[@R19],[@R22]. Therefore, the supervision of injection technique during the follow-up of patient by nurse is important to achieve a successive insulin treatment. The aim of this study was to evaluate the insulin pen injection knowledge and skills of patients with diabetes.

Methods
=======

Study design and participants
-----------------------------

This descriptive study was conducted in the Department of Endocrinology and Metabolism out-patient clinic in a training hospital between January and June 2015 in Ankara, Turkey.

The eligibility criteria for the patients were: (1) being 18 years of age or older; (2) being diagnosed with type 1 and/or 2 diabetes and not pregnant; (3) being a volunteer, and (4) being prescribed 1 or more of the disposable insulin pens for a minimum of 8 weeks. The criterion of eight weeks insulin pen use was chosen to observe the alteration in HbA1c levels. Red blood cells in the human body survive for 8--12 weeks before renewal, HbA1c can be used to reflect average blood glucose levels over that duration, providing a useful longer-term gauge of blood glucose control[@R5].

During the data collection period, 232 patients with diabetes visited the out-patient clinic in 6 months. 32 patients were excluded due to not being able to volunteer to participate in the study (n= 14), using insulin pen for less than 8 weeks (n= 8), and not being able to self-administer the insulin pen (n= 10). Consequently, 200 patients who met the research criteria and were willing to participate were enrolled in this study.

Ethical considerations
----------------------

Ethical approval, which agreed with the principles in the Declaration of Helsinki (2013), was obtained by the local university institutional review board (Document Number: 50687469-1491-61-14/16484-99). Patient signed informed consent before data collection. After data collection, the patients who were incorrectly implementing the steps of insulin injection were trained by the researchers and steps were repeated on a mannequin until the erroneous implementation is corrected.

Measurement instruments
-----------------------

Socio-demographic and medical backgrounds of patients were asked using the "socio-demographic and clinical characteristics form" and the insulin pen using techniques steps were checked with the "insulin pen injection technique checklist".

Socio-demographic and clinical characteristics form
---------------------------------------------------

This form, comprise of socio-demographic questions and data related to diabetes, was developed by the researchers in light of medical literature[@R12],[@R19],[@R20]. The socio-demographic data comprised of age, gender, marital status, educational status, employment status, exercise and smoking. Diabetes-related data included; type, duration of diabetes, duration of insulin therapy, difficulty in injection, daily insulin injection times. Researchers also questioned presence of hypertension and dyslipidemia of patients.

The HbA1c and other parameters were collected from the patients\' medical records that existed for last 3 months. The body mass index (BMI) was calculated based on height and weight \[BMI=weight (kg)/(height (m)^2^\][@R23].

Injection sites on patient\'s body were checked with observation and palpation for (1) lipodystrophy (lipohypertrophy, lipoatrophy), (2) bleeding and/or (3)bruise; the presence of at least one of them was accepted as a complication[@R10],[@R15],[@R24],[@R25].

Insulin pen injection technique checklist
-----------------------------------------

This checklist comprises the rules or informations that related to insulin pen injection developed based on the disposable insulin pen manufacturer instructional guidelines and articles referencing insulin injection technique and storage[@R10],[@R26]. The checklist comprises 19 items under 3 main section ([Table 2](#T2){ref-type="table"}). The sections were: (1) Preparation and Knowledge about Insulin Pen, (2) Site of Injection and Tissue, and (3) Using Devices and Injection Technique. Patients\' injection skills and their knowledge with regard to insulin injection were assessed with this form.

###### 

Evaluation of insulin pen using techniques of the participants\' (n=200)

  ---------------------------------------------------------------------------------------------------------------------
  Questions                                                                                   Correct      Incorrect
  ------------------------------------------------------------------------------------------- ------------ ------------
  **Preparation and Knowledge About Insulin Pen**                                                          

  **Q1.** Disposing the insulin pen or cartridge after expiry date even if it is not empty.   41 (20.5)    159 (79.5)

  **Q2.** Knowing the length of the needle.                                                   79 (39.5)    121 (60.5)

  **Q3.** Keeping the insulin pen and the spare cartridge in the right storage bag when\      165 (82.5)   35 (17.5)
  travelling.                                                                                              

  **Q4.** Keeping the insulin in the right storage conditions currently.                      165 (82.5)   35 (17.5)

  **Q5.** Keeping the insulin in the refrigerator at 2--8 °C when room temperature is\        167 (83.5)   33 (16.5)
  over 28 °C (in summer).                                                                                  

  **Q6.** Keeping the spare cartridge or insulin pen in the refrigerator.                     194 (97.0)   6 (3.0)

  **Site of Injection and Tissue**                                                                         

  **Q7.** Knowing the body injection sites.                                                   142 (71.0)   58 (29.0)

  **Q8.** Rotating the injection sites.                                                       59 (29.5)    141 (70.5)

  **Q9.** Grasping the injection site in the right position when injecting.                   197 (98.5)   3 (1.3)

  **Q10.** Not massaging the skin after injection.                                            74 (37.0)    126 (63.0)

  **Using Devices and Injection Technique**                                                                

  **Q11.** Able to change the cartridge when required.                                        185 (92.5)   15 (7.5)

  **Q12.** Using a new needle for each injection.                                             98 (49.0)    102 (51.0)

  **Q13.** Ejecting the excess air away before each injection.                                87 (43.5)    113 (56.5)

  **Q14.** Ejecting the excess air in the injector correctly.                                 91 (45.5)    109 (54.5)

  **Q15.** Correctly setting the prescribed dosage.                                           193 (96.5)   7 (3.5)

  **Q16.** Penetrating the skin with a right needle angle, and keeping it in the same\        199 (99.5)   1 (0.5)
  angle during injection.                                                                                  

  **Q17.** After penetrating the skin, pushing the injector piston correctly.                 198 (99.0)   2 (1.0)

  **Q18.** After injection, counting to ten before removing the needle.                       115 (57.5)   85 (42.5)

  **Q19.** Removing the needle with same penetration angle.                                   196 (98.0)   4 (2.0)
  ---------------------------------------------------------------------------------------------------------------------

"Q" Question.

Data collection procedure
-------------------------

In our department of endocrinology and metabolism out-patient clinic, insulin pen prescribed patients with diabetes are called for routine control visit at regular intervals by the physician, unless there is an emergency. When the patients with diabetes are prescribed insulin pen, they are trained on diabetes and insulin pen use by nurses. In the control visit, as a part of our study, after obtaining the signed consent, patients were asked to show how they inject the insulin on a mannequin without the researcher nurse\'s interference in the out-patient education room. Patients were observed during the insulin pen injection and their knowledge on the issue was assessed with reference to the Insulin pen injection technique checklist by the researchers. After injection practice on the model, patients\' body was examined to evaluate if there were any injection complications in the injection sides on their body.

During the observation, the researcher nurse was assessing the patients\' knowledge about the number of injections per day, needle length, the injection sites, whether the skin fold technique and rotation was being used, needle entry angle, the time the needle remains under skin, needle reuse, how to pull out the needle after injection, and the storage conditions. Each step of insulin pen injection was marked on the checklist as "correct" or "incorrect" by research nurse. The questions that could not be presented by patients on a mannequin were verbally asked to patients.

Data analysis
-------------

SPSS for Windows 15.0 (SPSS Inc., Chicago, IL., USA) package program was used for the data analysis. Data on descriptive statistics were presented in number, percentage and mean±standard deviation. "Correct/incorrect" steps on the insulin pen injection checklist and categorical variables were compared using a Chi-square test. p\<0.05 was accepted as statistically significant.

Results
=======

The mean age of the participant was 59.91 ± 11.29 (min: 23-max: 86) years. More than half of participants were female (59.0%), 77.0% were married, and 63.6% were primary school graduate. The majority of the participants (88.5%) had type 2 diabetes and mean duration of diabetes was 12.77 ± 7.36 years. The Socio-demographic and clinical characteristics of participants are presented in [Table 1](#T1){ref-type="table"}.

###### 

Socio-demographic and clinical characteristics of patients (n = 200)

  Characteristics                                       n (%)
  ----------------------------------------------------- ---------------
  **Age (years) (mean ± SD)**                           59.91 ± 11.29
  **Gender**                                            
  Female                                                118 (59.0)
  Male                                                  82 (41.0)
  **Marital status**                                    
  Married                                               154 (77.0)
  Single                                                46 (23.0)
  **Educational status**                                
  Primary school or less                                126 (63.0)
  High School                                           57 (28.5)
  University graduate or more                           17 (8.5)
  **Employment status**                                 
  Employed                                              24 (12.0)
  Unemployed                                            94 (47.0)
  Retired                                               82 (41.0)
  **Smoking**                                           
  Yes                                                   17 (8.5)
  No                                                    183 (91.5)
  **Hypertension**                                      
  Yes                                                   90 (40.0)
  No                                                    110 (60.0)
  **Dyslipidemia**                                      
  Yes                                                   191 (95.5)
  No                                                    9 (4.5)
  **Type of diabetes**                                  
  Type 1                                                23 (11.5)
  Type 2                                                177 (88.5)
  **Disease duration (years) (mean ± SD)**              12.77 ± 7.36
  **Duration of insulin therapy (years) (mean ± SD)**   7.56 ± 6.00
  **Difficulty in injection**                           
  Yes                                                   167 (83.5)
  No                                                    33 (16.5)
  **HbA1c (%) (mean ± SD)**                             10.48 ± 1.78
  **BMI (kg/m^2^) (mean ± SD)**                         31.86 ± 6.14
  **Regular exercise**                                  
  Yes                                                   76 (38.0)
  No                                                    124 (62.0)
  **Daily insulin injection**                           
  1--2 times                                            72 (36.0)
  3--4 times                                            128 (64.0)

Data have been presented as n (%) or mean ± standard deviation. HbA1C, Glycosylated hemoglobin A1C; BMI, Body mass index.

With regard to the participants\' insulin pen injection techniques, the most correct steps or knowledge were keeping the insulin pen in the same angle during injection (99.5%), grasping the injection site in the right position while injecting (98.5%), keeping the spare cartridge or insulin pen in the refrigerator (97.0%), correctly setting the prescribed dosage (96.5%) and penetrating the skin with a right needle angle. Also the most incorrect steps or knowledge were using the insulin pen or the cartridge after the expiry date (79.5%), not rotating the injection site (70.5%), massaging the skin after injection (63.0%) and ejecting the excess air away before each injection (56.5%) ([Table 2](#T2){ref-type="table"}.).

It was found that complications related to insulin injection were statistically more significant in participants who were using the insulin pen or the cartridge after the expiry date (x2 = 4.500; p = 0.034), who did not know the proper length of the needle (x2 = 10.880; p = 0.001) and the possible body injection sites (x2 = 3.310; p = 0.049), who didnot rotate the injection sites (x2= 7.698; p = 0.006), who massaged the skin after injection (x2= 6.056; p= 0.013), and who did not use a new needle at each injection (x2 = 10.305; p = 0.001) ([Table 3](#T3){ref-type="table"}).

###### 

Comparison of insulin pen using skills (correct/incorrect) and complications on the injection site (n=200)

  -------------------------------------------------------------------------------------------------------------------------------------
  Insulin Pen Using Skills                                                                                                    
  ----------------------------------------------------------------------------- -------- -------- --------- -------- -------- ---------
  **Preparation and Knowledge About Insulin Pen**                                                                             

  **Q1.** Disposing the insulin pen or cartridge after expiry\                  30\      11\      138\      21\      4.500    0.034\*
  date even if it is not empty.                                                 (73.2)   (26.8)   (86.8)    (13.2)            

  **Q2.** Knowing the length of the needle.                                     58\      21\      110\      11\      10.880   0.001\*
                                                                                (73.4)   (26.6)   (90.9)    (9.1)             

  **Q3.** Keeping the insulin pen and the spare cartridge in\                   138\     27\      30\       5\       0.093    0.761
  the right storage bag when travelling.                                        (83.6)   (16.4)   (85.7)    (17.5)            

  **Q4.** Keeping the insulin in the right storage conditions\                  136\     29\      32\       3\       1.742    0.187
  currently.                                                                    (82.4)   (17.6)   (91.4)    (8.6)             

  **Q5.** Keeping the insulin in the refrigerator at 2--8 °C\                   139\     28\      29\       4\       0.442    0.506
  when room temperature is over 28 °C (in summer).                              (83.2)   (16.8)   (87.9)    (12.1)            

  **Q6.** Keeping the spare cartridge or insulin pen in the\                    163\     31\      5\        1\       0.002    0.964
  refrigerator.                                                                 (84.0)   (16.0)   (83.3)    (16.7)            

  **Site of Injection and Tissue**                                                                                            

  **Q7.** Knowing the body injection sites.                                     115\     27\      53\       5\       3.310    0.049\*
                                                                                (81.0)   (19.0)   (91.4)    (9.6)             

  **Q8.** Rotating the injection sites.                                         43\      16\      125\      16\      7.698    0.006\*
                                                                                (72.9)   (27.1)   (88.7)    (11.3)            

  **Q9.** Grasping the injection site in the right position\                    165\     32\      3\        \-       0.580    0.446
  when injecting.                                                               (83.8)   (16.2)   (100.0)                     

  **Q10.** Not massaging the skin after injection.                              56\      18\      112\      14\      6.056    0.013\*
                                                                                (75.7)   (24.3)   (88.9)    (11.1)            

  **Using Devices and Injection Technique**                                                                                   

  **Q11.** Able to change the cartridge when required.                          154\     31\      14\       1\       1.051    0.305
                                                                                (83.2)   (16.8)   (93.3)    (6.7)             

  **Q12.** Using a new needle for each injection.                               74\      24\      94\       8\       10.305   0.001\*
                                                                                (75.5)   (24.5)   (92.2)    (7.8)             

  **Q13.** Ejecting the excess air away before each injection.                  69\      18\      99\       14\      2.520    0.112
                                                                                (79.3)   (20.7)   (87.6)    (12.4)            

  **Q14.** Ejecting the excess air in the injector correctly.                   74\      17\      94\       15\      0.893    0.345
                                                                                (81.3)   (18.7)   (86.2)    (13.8)            

  **Q15.** Correctly setting the prescribed dosage.                             162\     31\      6\        1\       0.016    0.900
                                                                                (83.9)   (16.1)   (85.7)    (14.3)            

  **Q16.** Penetrating the skin with a right needle angle,\                     167\     32\      1\        \-       0.191    0.662
  and keeping it in the same angle during injection.                            (83.9)   (16.1)   (100.0)                     

  **Q17.** After penetrating the skin, pushing the injector piston correctly.   166\     32\      2\        \-       0.385    0.535
                                                                                (83.8)   (16.2)   (100.0)                     

  **Q18.** After injection, counting to ten before removing\                    93\      22\      75\       10\      1.973    0.160
  the needle.                                                                   (80.9)   (19.1)   (88.2)    (11.8)            

  **Q19.** Removing the needle with same penetration\                           165\     31\      3\        1\       0.246    0.620
  angle.                                                                        (84.2)   (15.8)   (75.0)    (25.0)            
  -------------------------------------------------------------------------------------------------------------------------------------

p \< 0.05 statically significant.

x^2^, Pearson Chi- Square Test or Fisher Exact Test for some cells have expected count less than 5

In addition, frequency of having complications related to insulin injection on the injection side was statistically significantly higher in participants who were unemployed (p= 0.023), low educational status (p = 0.034), long-term insulin user (p = 0.015), experiencing difficulties in injection (p = 0.001), not exercising regularly (p = 0.007), and having more than two daily injections (p = 0.028) (not shown in the table).

Discussion
==========

This is one of the limited studies that have evaluated the insulin pen injection knowledge and skills of patients with diabetes. The results of this study showed that the majority of the patients with diabetes were keeping the spare cartridge or insulin pen in the refrigerator, grasping the injection site in the right position while injecting, correctly setting the prescribed dosage and penetrating the skin with a right needle angle, and keeping it in the same angle during injection. On the other hand, the majority of the patients were not disposing the insulin pen after the expiry date, not rotating the injection sites or massaging the skin after injection, not using a new needle for each injection.

Subcutaneous tissue is preferred for insulin injection because of the predictable absorption rate that allows a better glycemic control[@R14],[@R18],[@R26]. A less deep injection in the intradermal tissue may result in absorption at unpredictable rates, leakage and allergic reactions. Also because of the rich blood flow to the muscle, the risk of the insulin to be absorbed faster increases in intramuscular injection, which may lead to hypoglycemia and glycemic variations. Moreover, intramuscular injections are more painful and may result in bruises[@R14]. These reasons require patients to know the length of the needle, properly grasp the injection site, and inject in the correct location. However, in this study population, 60.5% did not know the length of the needle and most of them had complications. Patients using short needles such as 4 mm, 5 mm and 6 mm should not lift the skin and inject at a 90° angle[@R14],[@R18]. Moreover, massaging the skin after insulin injection may result in increased blood circulation on the injection site leading insulin to be absorbed very fast,[@R10],[@R21] increased tissue damage on the skin and in subcutaneous layer due to injection trauma, subcutaneous bleeding and bruising[@R24], [@R27]. Likewise, in this study it was found that the complication frequency was more in patients massaging after insulin injection.

One of the key points to be focused on is using a new needle for each injection. If the needle is not removed from the pen between two injections, air may leak into the injector causing wrong dose insulin injection. The injection should be given directly to the skin, because the needle can be blunt when administered through clothing and increase the risk of bleeding, bruising and infection[@R14],[@R17],[@R20]. Reusing the needle may result in distortion, bending and loss of lubrication. This can lacerate the skin[@R28] and cause painful injections[@R29]. Ji and Lou[@R12] reported that pen needle reuse was quite high in their study and this finding increased the risk of lipohypertrophy. Böhler et al.[@R30] found that only 40% of their study population was using a new needle for each injection. Likewise, Mitchell et al.[@R16] reported that one fifth of their population was keeping the needle attached on the pen, and 80% of them were removing the needle from the pen after at least three injections. Only half of the patients in this study were using a new needle for each injection. This number is very disappointing and requires special attention at patient education.

The correct rotation of injection sites is the strongest protective factor against the development of lipohypertrophy; [@R10],[@R12] Most of the participants in this study (70.5%) were not rotating the injection site moreover one of the complications such as lipodystrophy, bleeding and bruising was observed in patients who were not rotating regularly and massaging after injection. Similar to our results, several studies reported that high rate of not rotating the injection side and not controlling the skin for complications in patient with diabetes. In addition, all these studies reported that lipodystrophy occurred more frequent in patients with diabetes who did not rotate injection sites[@R31],[@R32].

The results of this study showed that frequency of having complications related to insulin injection was statistically significantly higher in participants who were longterm insulin user, experiencing difficulties in injection, having more than two daily injections. Our findings suggest that as long as the duration of insulin treatment and the numbers of daily injections increase, poorer injection techniques are adopted. Poor injection technique causes complications and unsatisfactory glycemic control[@R11],[@R22]. Patients may have forgotten the correct injection technique or neglected some of the steps over time. Therefore, not only the initial patient education on insulin pen use given by healthcare professionals is important, but also repetitive controls are important for a successful treatment protocol[@R19]. One of the major benefits of this study is having the opportunity to determine the erroneous steps of insulin injection and difficulties experienced by patients. This may shape the patient education and follow-up visits by focusing on the erroneous steps.

In the light of our findings, nurses should be focused on common erroneous topics when caring for patients who use insulin pen injector. We suggest that knowing which steps bear a difficulty for patients and nurses, in which errors are common, may help focusing and adjusting the education program and therefore improving the effectiveness and quality of education. Diabetes nurses should inform the patients and explain the effects of massaging the skin after insulin injection and keep patients away from massaging. Patients should be educated on how to make rotation, the importance of rotation and not using the area that lipohypertrophy occurred until the tissue gets normal, and they should be examined during each visit. Furthermore, they should be equipped with knowledge and skills to self-examine the injection sites on their body by inspection and palpation.

Limitations
===========

This study was conducted on patients with diabetes in a tertiary training and research hospital. Therefore, our results may not be generalized to patients who are admitted to and may not have sufficient support and service at primary or secondary health care facilities. In addition, it should be stated that the patients knew that they were being observed so they may have done some steps correctly.

Conclusion
==========

It is important to train the patients who start insulin injection therapy on injection techniques and control the steps of administration on follow-up visits. Healthcare professionals have the responsibility to equip the patients with adequate knowledge, skills and competence. The insulin injection skills of patients with diabetes were poor, and the incidence of complications was high in this study. As the duration of insulin therapy gets longer and the numbers of daily injections increase, incidence of complications on the injection site increases. Improved education in optimal insulin injection technique, especially focused on reducing needle reuse, correct rotation of injection sites and not massaging the skin after injection, should be emphasized.
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